In summary, our study reveals that patients with type 2 diabetes have higher circulating levels of the immunophilin cyclophilin A. Our observations that plasma cyclophilin A is higher in patients with type 2 diabetes irrespective of whether they have coronary artery disease or not indicates that hyperglycemia has an effect on cyclophilin secretion. Here, PPIA is linked to type 2 diabetes mellitus.